BIOMAT Database Logo BIOMAT Database Logo

The absolute bioavailability and effect of food on the pharmacokinetics of zolmitriptan in healthy volunteers. 1998

E J Seaber, and R W Peck, and D A Smith, and J Allanson, and N R Hefting, and J J van Lier, and F A Sollie, and J Wemer, and J H Jonkman
Glaxo Wellcome Research and Development, Greenford, Middlesex, UK.

OBJECTIVE Zolmitriptan (Zomig (formerly 311C90)) is a novel 5-HT1B/1D receptor agonist developed for the acute oral treatment of migraine. A highly sensitive LCMS-MS assay has been developed which allows quantification of plasma concentrations of zolmitriptan and its active metabolite, 183C91, after therapeutic doses. Two studies using this assay method were conducted to investigate the pharmacokinetics, including absolute bioavailability, of 2.5 and 5 mg oral doses of zolmitriptan in men and women, the dose-proportionality of 2.5, 5 and 10 mg doses and the effect of food on the pharmacokinetics of a 5 mg oral dose. METHODS Two randomized, balanced, open-label, 4-period crossover studies were conducted in a total of 32 healthy volunteers. The first study determined the absolute bioavailability of 2.5 and 5 mg doses of zolmitriptan and compared the pharmacokinetics in men and women. The second study examined the dose-proportionality in pharmacokinetics after fasting doses of 2.5, 5 and 10 mg, and the effect of food on a 5 mg dose. Blood pressure, heart rate, ECG, clinical chemistry, haematology and adverse events were also monitored. RESULTS The mean (s.d.) absolute oral bioavailability was 0.41 (0.14 and 0.40) 0.09 after 2.5 mg and 0.48+/-0.14 and 0.36+/-0.07 after 5 mg in women and men, respectively. Without adjustment for bodyweight, plasma concentrations of zolmitriptan, but not 183C91, were higher in women than men. Mean (+/-s.d.) AUC was 32.7+/-10.1 and 60.2+/-26.8 ng ml(-1) h after 5 mg in men and women, respectively (95% CI for ratio 0.43-0.77). After 2.5 mg mean (+/-s.d.) AUC was 18.4+/-5.4 and 23.1+/-9.9 ng ml(-1) h in men and women, respectively (95% CI for ratio 0.61-1.09). However, these differences were of no clinical significance. Cmax and AUC of oral zolmitriptan were dose-proportional and there was a 13 and 16% fall in mean zolmitriptan Cmax and AUC, respectively, when administered after food. Adverse effects were minor, predominantly mild and transient, and there were no clinically significant effects on ECG, blood pressure, or laboratory parameters. CONCLUSIONS At therapeutic doses zolmitriptan has good oral bioavailability in healthy volunteers and has dose-proportional pharmacokinetics that are not affected by food to any clinically relevant extent.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010080 Oxazoles Five-membered heterocyclic ring structures containing an oxygen in the 1-position and a nitrogen in the 3-position, in distinction from ISOXAZOLES where they are at the 1,2 positions. Oxazole,1,3-Oxazolium-5-Oxides,Munchnones,1,3 Oxazolium 5 Oxides
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D014363 Tryptamines Decarboxylated monoamine derivatives of TRYPTOPHAN. Indolylethylamines,Triptan,Triptans
D017366 Serotonin Receptor Agonists Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. 5-HT Agonists,5-Hydroxytryptamine Agonists,Serotonin Agonists,5-HT Agonist,5-Hydroxytrytamine Agonist,Receptor Agonists, Serotonin,Serotonergic Agonist,Serotonergic Agonists,Serotonin Agonist,Serotonin Receptor Agonist,5 HT Agonist,5 HT Agonists,5 Hydroxytryptamine Agonists,5 Hydroxytrytamine Agonist,Agonist, 5-HT,Agonist, 5-Hydroxytrytamine,Agonist, Serotonergic,Agonist, Serotonin,Agonist, Serotonin Receptor,Agonists, 5-HT,Agonists, 5-Hydroxytryptamine,Agonists, Serotonergic,Agonists, Serotonin,Agonists, Serotonin Receptor,Receptor Agonist, Serotonin

Related Publications

E J Seaber, and R W Peck, and D A Smith, and J Allanson, and N R Hefting, and J J van Lier, and F A Sollie, and J Wemer, and J H Jonkman
Characterization of the Pharmacokinetics of Samidorphan in Healthy Volunteers: Absolute Bioavailability and the Effect of Food and Age.
September 2019, Drugs in R&D,
E J Seaber, and R W Peck, and D A Smith, and J Allanson, and N R Hefting, and J J van Lier, and F A Sollie, and J Wemer, and J H Jonkman
Pharmacokinetics and absolute bioavailability of salbutamol in healthy adult volunteers.
January 1987, European journal of clinical pharmacology,
E J Seaber, and R W Peck, and D A Smith, and J Allanson, and N R Hefting, and J J van Lier, and F A Sollie, and J Wemer, and J H Jonkman
Intravenous pharmacokinetics and absolute oral bioavailability of dolasetron in healthy volunteers: part 1.
January 1999, Biopharmaceutics & drug disposition,
E J Seaber, and R W Peck, and D A Smith, and J Allanson, and N R Hefting, and J J van Lier, and F A Sollie, and J Wemer, and J H Jonkman
Effect of food on the bioavailability of pidotimod in healthy volunteers.
December 1994, Arzneimittel-Forschung,
E J Seaber, and R W Peck, and D A Smith, and J Allanson, and N R Hefting, and J J van Lier, and F A Sollie, and J Wemer, and J H Jonkman
Pharmacokinetics of intravenously and orally administered eprosartan in healthy males: absolute bioavailability and effect of food.
September 1998, Biopharmaceutics & drug disposition,
E J Seaber, and R W Peck, and D A Smith, and J Allanson, and N R Hefting, and J J van Lier, and F A Sollie, and J Wemer, and J H Jonkman
Complete bioavailability and lack of food-effect on pharmacokinetics of gliclazide 30 mg modified release in healthy volunteers.
May 2002, Biopharmaceutics & drug disposition,
E J Seaber, and R W Peck, and D A Smith, and J Allanson, and N R Hefting, and J J van Lier, and F A Sollie, and J Wemer, and J H Jonkman
The effect of food on cabergoline pharmacokinetics and tolerability in healthy volunteers.
July 1996, Biopharmaceutics & drug disposition,
E J Seaber, and R W Peck, and D A Smith, and J Allanson, and N R Hefting, and J J van Lier, and F A Sollie, and J Wemer, and J H Jonkman
Evaluation of the pharmacokinetics and absolute bioavailability of three isosorbide-5-mononitrate preparations in healthy volunteers.
February 1995, Arzneimittel-Forschung,
E J Seaber, and R W Peck, and D A Smith, and J Allanson, and N R Hefting, and J J van Lier, and F A Sollie, and J Wemer, and J H Jonkman
Pharmacokinetics and absolute bioavailability of ribavirin in healthy volunteers as determined by stable-isotope methodology.
October 1999, Antimicrobial agents and chemotherapy,
E J Seaber, and R W Peck, and D A Smith, and J Allanson, and N R Hefting, and J J van Lier, and F A Sollie, and J Wemer, and J H Jonkman
Absolute bioavailability, pharmacokinetics, and urinary excretion of the novel antimigraine agent almotriptan in healthy male volunteers.
December 2002, Journal of clinical pharmacology,
Copied contents to your clipboard!